how to stop using semaglutide GLP-1 drugs such as and tirzepatide are transforming obesity and diabetes care in India, but experts warn that improper use could lead significant muscle loss. A new India-specific consensus highlights what happens after you stop

Carnitine is a "vitamin-like" molecule that helps to transport long-chain fatty acids from outside the mitochondria (the energy powerhouse of the cell) to inside the mitochondria, a process that is vital to energy production

Clin Chim Acta 204:263277 Hoffmann GF, Athanassopoulos S, Burlina AB, Duran M, de Klerk JB, Lehnert W, Leonard JV, Monavari AA, Muller E, Muntau AC, Naughten ER, Plecko-Starting B, Superti-Furga A, Zschocke J, Christensen E (1996) Clinical course, early diagnosis, treatment, and prevention of disease in glutaryl-CoA dehydrogenase deficiency

Death to achieve the purpose of gaining health and prolonging life

Along with the drugs, the program also included intensive lifestyle interventions and coaching on diet, exercise, sleep and emotional health

Mounjaro (Tirzepatide) Dual action: targets both GLP-1 and GIP receptors Strong appetite suppression & improved blood sugar control Clinical trials show average body weight loss up to 22.5% over 72 weeks Wegovy (Semaglutide) Targets GLP-1 receptors only Licensed in the UK for obesity and cardiovascular protection STEP trials show 1521% body weight loss A new 7.2mg dose is expected in late 2025, with results potentially matching Mounjaro Both treatments are once-weekly injections, prescribed alongside healthy diet and lifestyle changes